A decrease in TDP1 activity in the U87 cell, by either knockdown or inhibitor, would be expected to decrease the IC50 of this relatively resistant GBM cell line, as demonstrated previously for other cancer cell lines [28,29,34]. The gene discussed is TDP1; the disease is glioblastoma.